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ABSTRACT
Objectives: To examine length of stay (LOS) and readmission rates for all minimally-invasive partial nephrectomy (MIPN) and MI radical nephrectomy (MIRN) performed for localized renal masses ≤7 cm in size (cT1RM) within 12 Michigan urology practices. Both RN
and PN are commonly performed in treating cT1RM. Although technically more complex and associated with higher complication rates,
Centers for Medicare & Medicaid Services considers MIPN an outpatient procedure and MIRN is inpatient.
Methods: We collected data for renal surgeries for cT1RM at MUSIC-KIDNEY practices between May 2017−February 2020. Data
abstractors recorded clinical, radiographic, pathologic, surgical, and short-term follow-up data into the registry for cT1RM patients.
Results: Within MUSIC-KIDNEY, 807 patients underwent MI renal surgery at 12 practices. Median LOS for cT1RM patients after
MIPN (n = 531, 66%) was 2 days and after MIRN (n = 276, 34%) was also 2 days. Among patients undergoing laparoscopic or robotic PN,
171 (32%), 230 (43%), and 130 (24%) stayed ≤1, 2, ≥3 days. Among patients undergoing laparoscopic or robotic RN, 81 (29%), 112
(41%), and 83 (30%) stayed ≤1, 2, ≥3 days. No significant difference was observed between MIPN and MIRN on LOS commensurate with
outpatient surgery (≤1-day, OR = 0.97, P = 0.87).
Conclusions: Less than one-third of patients had a LOS ≤1-day and LOS was comparable for MIPN and MIRN. Centers for Medicare &
Medicaid Services should be advised that MIPN is a more complex surgery than MIRN, most patients receiving a MIPN will require a ≥2-day
hospital stay and it would be more appropriate to classify MIPN an inpatient procedure with MIRN. Ó 2021 Elsevier Inc. All rights reserved.

Keywords: Small renal mass; Renal cell carcinoma; Partial nephrectomy; Outpatient surgery

1. INTRODUCTION
Minimally-invasive partial nephrectomy (MIPN),
including laparoscopic partial nephrectomy and robotic PN
Funding was provided in part by Blue Cross Blue Shield of Michigan and
within the Betz Family Endowment for Cancer Research (#RG0813-1036)
through the Spectrum Health Foundation.
*Corresponding author. Tel.: +616-267-7333; fax: +616-267-8040.
E-mail address: brian.lane@spectrumhealth.org (B.R. Lane).

(RPN), are paid by Centers for Medicare and Medicaid
Services (CMS) as a bundled payment under Medicare
Part B [1,2]. Some surgical procedures paid by Part B may
be performed at ambulatory surgical centers. Ambulatory
surgical centers eligible surgical procedures are those where
patients do not require hospitalization postoperatively [3].
The remainder of surgical procedures covered under Part B
must be performed in a hospital. CMS staff make these
determinations on a case-by-case basis, including MIPN.

https://doi.org/10.1016/j.urolonc.2021.01.001
1078-1439/Ó 2021 Elsevier Inc. All rights reserved.
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Hospital only Part B procedures are recognized to pose a
significant risk to beneficiary safety and should be expected
to require an overnight stay [4,5]. For surgical patients this
would equate to discharge before midnight on postoperative
day 1 (POD1). Postoperative care costs after a Part B procedure are included in the payment [6,7].
In contrast, minimally-invasive radical nephrectomy
(MIRN) is paid by CMS’ inpatient prospective payment
system under Medicare Part A and is an inpatient only procedure [8]. Procedures are considered inpatient due to the
“nature of the procedure, the typical underlying physical
condition of patients who require the service, or the need
for at least 24 hours of postoperative recovery time or monitoring before the patient can be safely discharged.” Payment for Part A procedures covers all charges related to an
inpatient stay from the time of admission to discharge [6].
This payment is adjusted significantly depending on the
diagnosis-related group (DRG) assignment at discharge. A
DRG is based on: the principal diagnosis, secondary diagnoses, surgical procedure performed, patient comorbidities,
postoperative complications, and disposition status [9].
MIRN has 3 different DRGs which are assigned after
reviewing the aforementioned factors [8]. The CMS classification of inpatient vs. observation level care is largely
administrative, as MIRN and MIPN must be performed in
hospital settings and postoperative care for both procedures
are likely delivered in the same units and hospital beds
[10].
Utilization of MIPN continues to increase nationally
for the treatment of renal masses (RM) and is the recommended surgical treatment in the 2017 AUA guidelines when feasible [11]. MIPN surgical procedures are
often more technically complex, with higher rates of
postoperative complications, and increased rates of
blood transfusion compared to MIRN [12,13]. We
hypothesize that MIPN does not meet outpatient classification in the current CMS reimbursement system and is
more appropriately classified as an inpatient procedure,
similar to MIRN.
Prior work has shown that discharge on POD1 is possible after MIPN in selected patients within different institutional series and national datasets [14-17]. Additionally,
there is 1 case report where a healthy, young patient
underwent outpatient MIPN [18]. Outpatient MIRN, has
been demonstrated in a small cohort case series with significant postdischarge provider support [19]. We build on
this prior work by comparing length of stay (LOS) of
patients who underwent MIPN or MIRN in a registry of
community, solo-practitioner, and academic urology practices within the state of Michigan. We specifically compared patient, surgeon, and practice demographics to
determine factors associated with LOS. Our findings are
intended to provide policymakers, CMS, and insurance
providers with insight regarding expected LOS for MIPN
and MIRN.

2. METHODS
2.1. Practices and Patients
Since 2011, the Michigan Urological Surgery Improvement Collaborative (MUSIC) has functioned as a physician-led quality improvement consortium. MUSIC began
collecting data regarding patients with RMs in 2017. The
MUSIC Kidney mass: Identifying and Defining Necessary
Evaluation and therapY (MUSIC−KIDNEY) program
seeks to standardize and improve care for patients with a
localized RM ≤7 cm (cT1RM) [15]. Trained data abstractors at each site review the patient medical records who
present with cT1RMs suspicious for renal cell carcinoma
and enter data elements into a web-based registry. For this
study, 44 physicians from 12 MUSIC practices participated.
The practice settings were diverse, consisting of 2 academic
practices, 9 community practices, and 1 single physician
practice. Patients with non-suspicious lesions, including
Bosniak I-IIF cysts and angiomyolipomas, and those with
clinical T2 or higher RMs were excluded. All participating
sites obtained exemption or approval from local institutional review boards before beginning data collection.
Our primary outcome was LOS for MIPN compared to
MIRN in the MUSIC-KIDNEY cohort. In this cohort, we
defined LOS as ≤1-day if the patient was discharged before
midnight the day after surgery, LOS as 2 days if discharged
before midnight 2 days postoperatively, and LOS ≥3-days
if discharged on POD3 or later. Patients were classifiable as
observation status if discharged ≤1-day after surgery and
inpatient status if discharged ≥2-days after surgery. We
then examined the patient, tumor, and surgeon characteristics associated with these LOS groups.
2.2. Payment Model Calculations
Each DRG for inpatient procedures, such as MIPN, is
assigned a relative weight and; therefore, payment based on
usual postoperative care required under Medicare Part A.
The lowest DRG assignment is designated to a patient who
does not experience postoperative complications and is relatively healthy (without complication or comorbidity
[CC]). The middle DRG assignment is made if a patient has
CC that complicate their postoperative hospital course. The
last DRG assignment is made if a patient experiences major
CC after surgery. If a beneficiary does experience major
CC, the DRG relative weight and; therefore, episode payment, would more than double compared to an uncomplicated stay (w/o CC) [3].
After a DRG assignment is made, the hospital payment
is calculated by specific geographic modifiers and an indirect graduate medical expense upcharge if the care was provided at a teaching hospital. Upcharges for rural hospitals,
disproportionate share payments, value-based purchasing
adjustments, or hospital readmissions reduction program
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are technically complex calculations with data not readily
available for analysis, but provide significant increases in
payment if applied [20,21]. They are excluded from the
sample payments.
The calculations below are based on the following formula per CMS: (fiscal year 2020 CMS base payment rate) *
(DRG assignment) * (Base rate geographic adjustment factors). The FY 2020 CMS base payment rate is $5,797 [22].
Three representative MUSIC-KIDNEY practice locations
are shown to demonstrate geographic differences in payment (Supplementary Table 1).
In contrast, Medicare beneficiaries are initially admitted
as observation status after MIPN and paid under Medicare
Part B. Their hospital payment is bundled and does not
allow for modifications in payment based on CC. There is
not an upcharge for indirect graduate medical expense costs
if the procedure was performed at a teaching hospital. There
is an adjustment for local wages based on geographic location. The calculations below are based on the following formula: [(FY 2020 CMS MIPN unadjusted payment rate) *
(wage index) * 60%] + [(FY 2020 CMS MIPN unadjusted
payment rate) * 40%] [23]. Hospital payment for MIPN at
an unadjusted rate is $8,523.31 for the 2020 fiscal year
[24]. Supplementary Table 1 shows the MIPN estimated
payment calculations.
Modifications for outlier cases with substantially
increased costs may be made under Medicare Part B but is
done on a case-by-case basis. Outlier cases have to exceed
the cost of typical payment by 1.75-fold, and hospitals
are only paid 50% of the amount over the 1.75 factor
amount [12].
2.3. Statistical Analysis
We compared clinical and demographic characteristics of
patients, as well as, physician- and practice-level characteristics between MIPN and MIRN, using chi-squared test for categorical variables and Student’s t test for continuous
measures. We assessed the proportions of outpatient procedure (LOS ≤ 1-day) across patient-, physician- and practicelevel factors. We used a mixed effects logistic regression
model to evaluate the rate of outpatient procedure between
MIPN and MIRN. The model included procedure type as the
primary predictor variable, with MIRN as the reference
group. The model included as covariates patient-, physician-,
and practice-level characteristics. We included random intercepts for each urologist to account for within-physician correlation. All the analyses were performed using SAS 9.4 and
statistical significance was set at 0.05.
3. Results
Of these cT1RM patients, 927 (51.2%) patients underwent immediate definitive treatment, and 881 (48.7%) are
undergoing active surveillance without any initial intervention. Eight hundred and thirty-two patients underwent a

3

Table 1
Features of patients undergoing minimally-invasive renal surgery for clinical T1 renal mass
Variable
No. patients
Age
BMI
Tumor size
Tumor stage
T1a
T1b
Race
White
AfricanAmerican
Other
Unknown
Gender
Male
Female
Insurance type
Private
Public
None/Unknown
Charlson
Comorbidity
Index
0
1
≥2
Renal mass biopsy
Biopsy
No biopsy
Surgical approach
Robotic
Laparoscopic
Fellowship trained
surgeon
Yes
No
Surgeon
completed
training
Before 2000
2000−2009
2010 or later

All

MIPN

MIRN

P value

807
59.5 (12.3)
31.7 (7.0)
3.5 (1.5)

531
57.8 (12.4)
31.9 (7.1)
2.9 (1.2)

276
62.8 (11.5)
31.3 (6.6)
4.7 (1.4)

<0.001
0.30
<0.001

515 (63.8%)
292 (36.2%)

430 (81.0%)
101 (19.0%)

85 (30.8%)
191 (69.2%)

0.000

629 (77.9%)
102 (12.6%)

424 (79.8%)
63 (11.9%)

205 (74.3%)
39 (14.1%)

0.31

15 (1.9%)
61 (7.6%)

9 (1.7%)
35 (6.6%)

6 (2.2%)
26 (9.4%)

484 (60.0%)
323 (40.0%)

323 (60.8%)
208 (39.2%)

161 (58.3%)
115 (41.7%)

0.49

495 (61.3%)
297 (36.8%)
15 (1.9%)

348 (65.5%)
174 (32.8%)
9 (1.7%)

147 (53.3%)
123 (44.6%)
6 (2.2%)

0.003

474 (58.7%)
141 (17.5%)
192 (23.8%)

321 (60.5%)
96 (18.1%)
114 (21.5%)

153 (55.4%)
45 (16.3%)
78 (28.3%)

0.099

116 (14.4%)
691 (85.6%)

81 (15.3%)
450 (84.7%)

35 (12.7%)
241 (87.3%)

0.32

674 (83.5%)
133 (16.5%)

485 (91.3%)
46 (8.7%)

189 (68.5%)
87 (31.5%)

<0.001

655 (81.2%)
152 (18.8%)

436 (82.1%)
95 (17.9%)

219 (79.3%)
57 (20.7%)

0.34

179 (22.2%)
417 (51.7%)
211 (26.1%)

91 (17.1%)
304 (57.3%)
136 (25.6%)

88 (31.9%)
113 (40.9%)
75 (27.2%)

<0.001

Values are n (%) or mean (SD).

minimally invasive surgery (MIPN or MIRN). Patients
included in this study are patients who underwent MIRN or
MIPN for cT1RM between May 2017 and February 2020;
patients undergoing open surgery (n = 31), other interventions (n = 64), or no interventions (n = 881) were excluded,
as well as, those with incomplete outcomes data (n = 25).
Within MUSIC-KIDNEY, 531 patients underwent
MIPN (66%) and 276 patients underwent MIRN (34%) for
cT1RM. Table 1 shows patient and surgeon factors by procedure type. Patients were more likely to receive a MIPN if
they were younger (P < 0.0001), had a smaller tumor (P <
0.0001), or had private insurance (P = 0.003). MIPN were
also more likely to be performed using robotic approach
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Fig. 1. Day of discharge following minimally-invasive partial nephrectomy and radical nephrectomy. Labels indicated the number of patients discharged
within each cohort. The y-axis indicates percentage of the cohort.

and by urologists who completed training after 2000 (P <
0.001). BMI, race, gender, Charlson Comorbidity Index
(CCI), and preoperative RM biopsy were not associated
with type of surgery.
Hospital LOS of the MIPN and MIRN groups were
nearly identical (Fig. 1). Following MIPN, 32.2% of
patients had a LOS ≤ 1 day, 43.3% had LOS = 2 days, and
24.5% had LOS ≥ 3 days. Following MIRN, 29.3% of
patients had LOS ≤ 1 day, 40.6% had LOS = 2 days, and
30.1% had LOS ≥ 3 days (P = 0.229). Median LOS for
MIRN and MIPN were both identical at 2 days.
Table 2 lists patient factors associated with outpatient
procedure (LOS ≤ 1 day). Younger age (P < 0.0001), tumor
size (P < 0.0001), private insurance (P = 0.012), and patient
comorbidities measured via CCI (P = 0.009) were associated with a LOS ≤ 1 day. There were clear associations
between LOS and both tumor size and patient age (Supplementary Table 2). However, even in the most favorable subgroups, the proportion of outpatient procedures classified as
observation was only 42% (67/159) of those with tumors
<2 cm, 41% (83/202) of patients ≤50 years, and 35% (166/
474) of those without comorbidities. Surgeon-specific factors such as fellowship training or years in practice were
not associated with LOS. Surgical approach (laparoscopic
vs. robotic) was not associated with LOS for patients undergoing MIPN or MIRN (P = 0.263). BMI, race, and gender
did not have an effect on LOS.
On multivariable analysis (Table 3), there was no significance difference between MIPN and MIRN on outpatient
surgery status (OR = 0.98, P = 0.91) controlling for patient, physician-, and practice-level factors. Older patients
(OR = 0.98, P = 0.001) and patients with more comorbidities (OR = 0.86, P = 0.044) were less likely to have an outpatient surgery. In the model, tumor size was excluded
because the estimates became misleading. This is due to the
high correlation of procedure and tumor size with little
overlap between surgical approach. When procedure type
(MIPN vs. MIRN) is omitted from the model, tumor size is

a significant predictor of LOS (data not shown), as indicated
in Supplementary Table 2.
Readmission within 30 days of surgery occurred in 3.5%
of patients (n = 28), including 2.8% of MIPN (n = 15) and
4.7% of MIRN (n = 13). Following LOS ≤1-day and LOS
≥2-days, 30-day readmission rates were 2.4% and 4.0%.
MIRN and LOS ≥2-days appeared to be associated with
higher 30-day readmission rates, although the difference
did not reach conventional statistical significance (P =
0.165 and P = 0.255, respectively).
4. Discussion
This registry of patients across diverse practices shows
no appreciable difference in LOS between MIPN and
MIRN for cT1RM. LOS commensurate with observation
status (LOS ≤ 1-day) only occurred in a minority of patients
(<33%) following either procedure. Surgical approach, laparoscopic or robotic, did not have an appreciable effect on
LOS or 30-day readmissions after surgery. Multivariable
analysis revealed that older age and more comorbiditieswere associated with inpatient vs. outpatient surgery, but
even in the most favorable categories (age <50-years, no
comorbidities [CCI = 0], and tumor size ≤2 cm), rates of
outpatient surgery were no higher than 42%. Collectively,
these findings demonstrate a similar pattern of LOS for
patients undergoing MIPN vs. MIRN, with 69% of patients
in our cohort staying 2 or more midnights.
Nationally, the 2020 CMS arithmetic LOS for MIRN is
2.5−7.5 days depending on DRG assignment [3,18]. However, hospitals have continued to increase observation stays,
decrease inpatient stays, and are reluctant to transition a
patient from observation to inpatient status due to fear of
audit and possible denial of payment [25,26].
Payment differences still persist between an uncomplicated MIPN and MIRN. If a healthy index patient undergoes MIPN in Detroit, MI the payment is $8,024.63
(Fig. 2). If that same patient underwent MIRN and spent
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Table 2
Features of patients undergoing MIRN and MIPN according to LOS
Outpatient Surgery (LOS ≤1 day)

Inpatient Surgery (LOS 2 day or more)

P value

807
59.5 (12.3)
31.7 (7.0)
3.5 (1.5)

252 (31.2%)
56.7 (12.2)
31.7 (6.9)
3.2 (1.4)

555 (68.8%)
60.8 (12.2)
31.7 (7.0)
3.7 (1.5)

<.0001
0.93
<.0001

515 (63.8%)
292 (36.2%)

178 (34.6%)
74 (25.3%)

337 (65.4%)
218 (74.7%)

0.007

629 (77.9%)
102 (12.6%)
15 (1.9%)
61 (7.6%)

188 (29.9%)
30 (29.4%)
8 (53.3%)
26 (42.6%)

441 (70.1%)
72 (70.6%)
7 (46.7%)
35 (57.4%)

0.051

484 (60.0%)
323 (40.0%)

161 (33.3%)
91 (28.2%)

323 (66.7%)
232 (71.8%)

0.13

495 (61.3%)
297 (36.8%)
15 (1.9%)

170 (34.3%)
75 (25.3%)
7 (46.7%)

325 (65.7%)
222 (74.7%)
8 (53.3%)

0.012

474 (58.7%)
141 (17.5%)
192 (23.8%)

166 (35.0%)
42 (29.8%)
44 (22.9%)

308 (65.0%)
99 (70.2%)
148 (77.1%)

0.009

116 (14.4%)
691 (85.6%)

35 (30.2%)
217 (31.4%)

81 (69.8%)
474 (68.6%)

0.79

674 (83.5%)
133 (16.5%)

205 (30.4%)
47 (35.3%)

469 (69.6%)
86 (64.7%)

0.26

655 (81.2%)
152 (18.8%)

200 (30.5%)
52 (34.2%)

455 (69.5%)
100 (65.8%)

0.38

179 (22.2%)
417 (51.7%)
211 (26.1%)

65 (36.3%)
115 (27.6%)
72 (34.1%)

114 (63.7%)
302 (72.4%)
139 (65.9%)

0.062

Variable
No. patients
Median age, years (SD)
BMI, units (SD)
Tumor size, cm (SD)
Tumor stage
T1a
T1b
Race
White
African-American
Other
Unknown
Gender
Male
Female
Insurance type
Private
Public
None/unknown
Charlson Comorbidity Index
0
1
≥2
Renal mass biopsy
Biopsy
No Biopsy
Surgical approach
Robotic
Laparoscopic
Fellowship trained surgeon
Yes
No
Surgeon completed training
Before 2000
2000−2009
2010 or later

All

Values are n (%) or mean (SD).

Table 3
Multivariable analysis of factors associated with having an outpatient procedure (LOS ≤1 day)

MIPN (vs. MIRN)
African-American (vs. White)
Other race (vs. White)
Unknown race (vs. White)
Female gender (vs. Male)
Public insurance (vs. Private)
No or unknown insurance (vs. Private)
Renal mass biopsy (vs. no biopsy)
Robotic surgery (vs. laparoscopic)
Fellowship-trained surgeon (vs. not)
Completed training in 2000−2009
(vs before 2000)
Completed training in 2010 or later
(vs. before 2000)
Age
BMI
Charlson Comorbidity Index

OR

95% CI

P value

0.98
0.93
2.35
1.35
0.77
0.83
1.40
0.99
0.85
1.09
0.48

(0.67, 1.43)
(0.56, 1.55)
(0.78, 7.14)
(0.73, 2.49)
(0.55, 1.08)
(0.57, 1.21)
(0.45, 4.41)
(0.61, 1.59)
(0.53, 1.37)
(0.52, 2.27)
(0.21, 1.08)

0.91
0.78
0.13
0.33
0.13
0.33
0.56
0.96
0.50
0.82
0.08

0.89

(0.43, 1.84)

0.76

0.98
1.00
0.86

(0.96, 0.99)
(0.97, 1.02)
(0.73, 1.00)

0.001
0.68
0.044

The model is controlled for surgeon thru random effects. Tumor size has
been excluded because the estimates became unstable and misleading as
procedure type (PN vs. RN) and tumor size are highly correlated and there
is little overlap between PN and RN according to tumor size.

1.5 days in the hospital, the payment would be $10,104.87.
Payment differences become more apparent with complicated cases. For example, if a complicated MIPN requiring
a several days LOS was performed and cost $17,500, the
hospital would be paid $8,024.63 plus an outlier payment
of $1,752.42 if the patient remained observation status after
surgery. This example hospital would have a negative profit
of $7,464.63. In comparison, if this same case was instead a
MIRN and met the highest DRG assignment, the hospital
would have a net profit of $120.16. It is important to note
that a Medicare beneficiary can transition to inpatient status
after MIPN and would transition to the DRG assignments
previously listed.
A possible illustration of these payment differences
nationwide can be seen in recent work by Ellimoottil and
co-authors who utilized the SEER database from 2008 to
2011. They demonstrated a significant difference in mean
hospital episode payment for RN ($18,052) and PN
($15,910) [27]. However, they did not differentiate between
open PN and MIPN which may skew results, as open PN
is an inpatient only procedure utilizing the same DRG
assignments.
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Fig. 2. Estimated CMS payment to a hospital after a Medicare beneficiary undergoes a MIPN or MIRN for a patient without complication or complexity (no
CC), with CC, or with major CC.

Patient costs are significantly affected by a status of
inpatient or observation at discharge. After MIRN, under
Medicare Part A, patients are charged a deductible for
their hospital episode, this amount is $1408 for 2020.
Their deductible covers readmissions 60 days after hospitalization and postacute nursing care after discharge [24].
After MIPN, under Medicare Part B, patients are charged
via a cost sharing model payment. Their deductible is
lower than Part A, $198 in 2020, but patients pay 20% of
services such as doctor services, medical equipment, and
medication related to their hospital stay. The patient’s
self-administered home medications are not covered under
Medicare Part B and are directly charged to the patient
adding to their out-of-pocket costs [12]. If a patient is
readmitted to the hospital after their initial observation
stay for MIPN, they pay another deductible which may be
another observation deductible under Part B, or the higher
inpatient deductible under Part A leading to total out of
pocket costs that may surpass the cost of the inpatient
deductible [28].
We evaluated MIRN and MIPN patients by LOS to identify factors that may identify patients who could be predicted to undergo a LOS ≤1-day. Patients that were
younger, had smaller tumors, private insurance, and no
comorbidities were more likely to have an outpatient procedure. Nevertheless, the LOS ≤1-day rates in the most favorable groups still did not exceed 42%. Prior analysis of
retrospective data by other groups found that similar factors
affect LOS after RPN, but they were unable to develop an
accurate LOS prediction tool that could be used to identify
candidates for outpatient surgery [29]. On multivariate
analysis, we found that 2 factors affected LOS ≤1-day:
patient age and CCI ≥2, with no significant difference

between MIPN and MIRN. A prior retrospective study
showed that POD1 discharge after a RPN for cT1RMs
appeared safe without an increase in postoperative complications [17]. However, this was in a highly selected group
of patients who underwent preoperative education and are
not applicable broadly due to increased resource requirements and patient differences.
The current study found a higher (albeit statistically
insignificant) 30-day readmission rate for patients with a
LOS ≥2 days compared to those with ≤1-day (3.96% vs.
2.38%, P = 0.255). Prior work evaluated the American College of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP) database to determine 30-day postoperative complications between RN and PN. Authors from
that work argued that PN should be considered inpatient
based solely on the similar complication rates [13]. Their
work is misleading as they did not differentiate between
open PN or MIPN, the former has always been an inpatient
only procedure. Our analysis adds the findings that duration
of hospitalization and 30-day readmission rates are no
different.
Our study does have several limitations. First, we do not
have final hospital billing information regarding payment
for each patient undergoing MIPN or MIRN. However, we
did demonstrate that there were no observable differences
on LOS. While both the observed and adjusted analysis in
this study demonstrated no significant difference between
MIPN and MIRN on LOS, we did notice that the confidence
interval for the estimated effect was quite wide
(0.67−1.43). Although the point estimate was suggestive of
no difference between the 2 groups, the study sample size
limits our ability to obtain a more precise estimate. Second,
while we have solid data regarding the actual LOS for each
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patient, we cannot evaluate which patients were transitioned to inpatient status after initial observation status,
which affects hospital payment. Finally, prior work has
demonstrated shorter LOS in highly selected MIPN and
MIRN groups with extensive patient education
[14,17,18,30]. Nonetheless, our real-world cohort is likely
more applicable on a national level, as it is composed of
diverse patient populations and urology practices.
These limitations notwithstanding, our findings have
important implications for patients, physicians, payers, and
policymakers. MIPN when feasible is the standard of care,
compared to MIRN even though they are often more complex with higher known complication rates. Under current
Medicare payment model, the hospital payment for MIPN
is less than MIRN for those patients with an uncomplicated
postoperative stay. As complexity, complications, and LOS
increase, the difference in hospital payment for MIPN vs.
MIRN widens. Policymakers should consider MIPN as an
inpatient procedure in conjunction with MIRN, based on
our findings to more accurately reflect the time and effort of
usual postoperative care.
5. Conclusions
In our study of patients undergoing surgery for cT1RM
within a diverse patient registry, we demonstrated that MIPN
and MIRN were associated with similar LOS and similar 30day readmission rates. A majority of patients undergoing
MIPN required hospitalization of ≥ 2-days. This does not
meet classification as on observation status stay after surgery
and has significant effects on hospital payment and patient
out of pocket costs. The current administrative CMS classification of MIPN should be reviewed by patients, providers,
and policymakers, as it can have significant impact on patient
care, patient out of pocket costs, and hospital payment.
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